Ajax-Loading

AbbVie Inc - Price To Cashflow Ratio

AbbVie Inc's Fiscal Year is From January To December.

The item "Price-To-Cashflow-Ratio" stands at 18.09 as of 09/30/2025.

As of the end of AbbVie Inc's third quarter, the item "Price To Cashflow Ratio" stands at 18.09. This represents an increase of 12.00 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -8.22 percent compared to the value the year prior.
The 1 year change in percent is -8.22.
The 3 year change in percent is 71.81.

The Serie's long term average value is 13.45. It's latest available value, on 09/30/2025, is 34.50 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2023, to it's latest available value, on 09/30/2025, is +117.44%.
The Serie's change in percent from it's maximum value, on 03/31/2025, to it's latest available value, on 09/30/2025, is -14.42%.

Price To Cashflow Ratio for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Price To Cashflow Ratio905,699,262,464.00
LogoJohnson & Johnson - Price To Cashflow Ratio486,508,953,600.00
LogoRoche Holding AG - Price To Cashflow Ratio317,433,206,677.55
LogoAstraZeneca PLC - Price To Cashflow Ratio280,205,508,085.11
LogoNovartis AG - Price To Cashflow Ratio255,096,620,580.91